PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruce Schneider, General Medicine Team Leader at CDER/FDA to Speak at Diabetes Summit on March 8 - Bruce Schneider, General Medicine Team Leader, Cellular, Tissue, and Gene Therapies, at CDER/FDA will give a featured presentation at the Diabetes Summit to be held in Philadelphia, PA on March 7-8 by GTCbio
Bruce Schneider, General Medicine Team Leader at CDER/FDA to Speak at Diabetes Summit on March 8

 

NewswireToday - /newswire/ - Philadelphia, PA, United States, 2011/01/15 - Bruce Schneider, General Medicine Team Leader, Cellular, Tissue, and Gene Therapies, at CDER/FDA will give a featured presentation at the Diabetes Summit to be held in Philadelphia, PA on March 7-8 by GTCbio.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Schneider will focus on the regulation of new islet beta cell products for treatment of type 1 diabetes. This included allogeneic, embryonic stem cell, and xenogeneic-derived cells.

Also presenting at the Diabetes Summit are prestigious organizations including Sanofi-Aventis, VeroScience LLC, INSERM, Thermalin, Merck, Decision Resources, Metabolic Solutions Development Company, Pfizer, Inspherion, PhysioGenix, Intarcia Therapeutics, Inc., University of Pennsylvania, Abramson Family Cancer Research Institute, Exsulin Corporation, Arisaph Pharmaceuticals, ActivX, Amarex Clinical Research, Children's Hospital of Philadelphia, Division of Endocrinology & Diabetes, Johnson and Johnson, Macrogenics, Phase Bioscience, Novo-Nordisk Foundation Center for Basic Metabolic Research University of Copenhagen, Merck, Array BioPharma, Comus Bioventures, VIA Pharmaceuticals, Amgen, and Bristol-Myers Squibb.

This Diabetes Summit includes two concurrent tracks: The 4th Diabetes Drug Discovery and Development Conference and the Diabetes Partnering and Deal Making Conference.

Bruce Schneider, General Medicine Team Leader, Cellular, Tissue, and Gene Therapies, at CDER/FDA will give a featured presentation at the Diabetes Summit to be held in Philadelphia, PA on March 7-8, 2011 by GTCbio. Dr. Schneider will focus on the regulation of new islet beta cell products for treatment of type 1 diabetes. This included allogeneic, embryonic stem cell, and xenogeneic-derived cells.

Also presenting at the Diabetes Summit are prestigious organizations including Sanofi-Aventis, VeroScience LLC, INSERM, Thermalin, Merck, Decision Resources, Metabolic Solutions Development Company, Pfizer, Inspherion, PhysioGenix, Intarcia Therapeutics, Inc., University of Pennsylvania, Abramson Family Cancer Research Institute, Exsulin Corporation, Arisaph Pharmaceuticals, ActivX, Amarex Clinical Research, Children's Hospital of Philadelphia, Division of Endocrinology & Diabetes, Johnson and Johnson, Macrogenics, Phase Bioscience, Novo-Nordisk Foundation Center for Basic Metabolic Research University of Copenhagen, Merck, Array BioPharma, Comus Bioventures, VIA Pharmaceuticals, Amgen, and Bristol-Myers Squibb.

This Diabetes Summit includes two concurrent tracks: The 4th Diabetes Drug Discovery and Development Conference and the Diabetes Partnering and Deal Making Conference.

For more information, visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bruce Schneider, General Medicine Team Leader at CDER/FDA to Speak at Diabetes Summit on March 8

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)